Studies on the recovery of uranium from nuclear industrial effluent using nanoporous silica adsorbent

In this paper, the sorption of uranium onto nanoporous silica adsorbent in the presence of nitrate, sulfate, chloride, fluoride and phosphate was studied. The effect of contact time between the nanoporous sorbent and aqueous solution, pH and initial concentration of uranium was also investigated. Uranium sorption onto nanoporous silica adsorbent is a very fast process as sorption rate increases with pH increment. Optimum pH for uranium sorption was 4–8. Experimental sorption isotherm is successfully described by Langmuir and Freundlich models. The results obtained by batch experiments showed that the presence of high concentration of nitrate, sulfate, chloride and phosphate anions alone had no interference with uranium recovery. However, the presence of fluoride ions (>250 mg/L) decreases uranium sorption by about 55 %. The results also showed that the presence of phosphate ions (about 300 mg/L) in solution could remove fluoride interference completely. Finally, the efficiency of the nanoporous silica adsorbent for uranium recovery from wastewater of the uranium conversion facility was investigated

Hypophosphatemia related to paraneoplastic Cushing syndrome in prostate cancer: cure after bilateral adrenalectomy.

We report the case of a 71-year-old man with progressive metastatic prostate cancer in whom simultaneous occurrence of paraneoplastic Cushing syndrome (CS) and tumor-induced osteomalacia (TIO) initially was suspected. However, the evolution of biochemical markers of phosphate metabolism during disease course and after bilateral adrenalectomy argued against the diagnosis of TIO. Despite the persistence of progressive prostate cancer, CS and hypophosphatemia resolved in parallel after bilateral adrenalectomy. Thus, these data suggest that paraneoplastic CS per se was involved in the pathogenesis of hypophosphatemia. Calcitriol and intact fibroblast growth factor 23 (FGF23) levels were within the reference range at onset, which is inappropriate in the setting of severe hypophosphatemia. All parameters of phosphate metabolism normalized after resolution of hypercortisolism. Based on the known suppressive effect of glucocorticoids (GCs) on bone remodeling and the inverse relationship between bone turnover rate and circulating FGF23 levels, we postulate that GCs interfere indirectly with phosphate homeostasis by inducing inappropriate FGF23 production and release. This mechanism could further aggravate the hypophosphatemia resulting from GC-induced inhibition of intestinal phosphate absorption. Studies directed at the identification of the molecular pathways in bone mediating the interference of GCs with phosphate metabolism are warranted.Case ReportsJournal ArticleSCOPUS: ar.jinfo:eu-repo/semantics/publishe